Proteomics R&D Competition In a Post Genome-Project Era

Research and Markets have announced the addition of the 'Proteomics R&D Competition In a Post Genome-Project Era report to their offering.

(PRWEB) December 24, 2003 --This is a new market research study that analyzes the major market segments in the emerging field of proteomics, the global study of protein profile changes due to developmental, environmental or disease states, and its application to the drug development process. The report examines seven market segments, including Emerging Proteomics Technologies, Proteomics Chip Providers, Proteomics Platform Providers, Reagent or Antibody Providers, Proteomics Informatics Tools and Database Providers, Proteomic Service Providers, and Proteomics-based Drug Discovery Companies.

The report also includes analysis of over 190 strategic alliances among the companies analyzed, as well as 50 in-depth profiles of Proteomics companies. Examples of companies profiled in the report are Iconix, Incyte, Celera Genomics, Oxford GlycoSciences, Zyomyx, Celera, SomaLogic, Ciphergen, Phylos, Affibody, and NeoGenesis.

This report is available in both English and Japanese editions.

For a complete index of this report click on http://www.researchandmarkets.com/reports/41818

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com
###